S.C. Olson

970 total citations
28 papers, 748 citations indexed

About

S.C. Olson is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Oncology. According to data from OpenAlex, S.C. Olson has authored 28 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Cognitive Neuroscience and 5 papers in Oncology. Recurrent topics in S.C. Olson's work include Functional Brain Connectivity Studies (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Schizophrenia research and treatment (4 papers). S.C. Olson is often cited by papers focused on Functional Brain Connectivity Studies (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Schizophrenia research and treatment (4 papers). S.C. Olson collaborates with scholars based in United States, Canada and China. S.C. Olson's co-authors include Henry A. Nasrallah, Jeffrey A. Coffman, Steven B. Schwarzkopf, David H. Kirn, Casey Cunningham, John Nemunaitis, Phillip B. Maples, George J. Netto, Britta Randlev and Gerald M. Edelman and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Brain Research.

In The Last Decade

S.C. Olson

28 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.C. Olson United States	13	242	226	180	165	125	28	748
Michael Steffens Germany	19	150 0.6×	290 1.3×	139 0.8×	61 0.4×	55 0.4×	60	1.1k
Lane J. Brunner United States	19	145 0.6×	242 1.1×	170 0.9×	45 0.3×	29 0.2×	52	1.1k
H. Krüger Germany	15	35 0.1×	151 0.7×	143 0.8×	100 0.6×	52 0.4×	24	1.1k
David Herion United States	15	107 0.4×	332 1.5×	27 0.1×	73 0.4×	48 0.4×	20	1.8k
Guy Lacombe Canada	16	37 0.2×	252 1.1×	35 0.2×	125 0.8×	41 0.3×	39	1.1k
Philip B. Conran United States	16	35 0.1×	269 1.2×	115 0.6×	102 0.6×	7 0.1×	32	795
Margaret A. Kenny United States	16	37 0.2×	147 0.7×	41 0.2×	31 0.2×	37 0.3×	42	750
Theresa Schneider United States	12	75 0.3×	305 1.3×	45 0.3×	280 1.7×	31 0.2×	21	1.0k
Calen A. Steiner United States	15	247 1.0×	168 0.7×	54 0.3×	184 1.1×	154 1.2×	31	888
Qing Cao China	15	31 0.1×	263 1.2×	37 0.2×	147 0.9×	31 0.2×	36	862

Countries citing papers authored by S.C. Olson

Since Specialization

Citations

This map shows the geographic impact of S.C. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.C. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.C. Olson more than expected).

Fields of papers citing papers by S.C. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.C. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.C. Olson. The network helps show where S.C. Olson may publish in the future.

Co-authorship network of co-authors of S.C. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of S.C. Olson. A scholar is included among the top collaborators of S.C. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.C. Olson. S.C. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olson, S.C., Stephen D. Smith, Scott J. Weissman, & Matthew P. Kronman. (2014). Adverse Events in Pediatric Patients Receiving Long-Term Outpatient Antimicrobials. Journal of the Pediatric Infectious Diseases Society. 4(2). 119–125. 25 indexed citations

Kaplan, Harvey, D G Taylor, & S.C. Olson. (2009). Quinapril: Overview of preclinical data. Clinical Cardiology. 13(S7). VII–6. 7 indexed citations

Olson, S.C., et al.. (2007). Modeling and Simulation to Support Dose Selection and Clinical Development of SC-75416, a Selective COX-2 Inhibitor for the Treatment of Acute and Chronic Pain. Clinical Pharmacology & Therapeutics. 83(6). 857–866. 23 indexed citations

Eder, Joseph P., Manuel Hidalgo, David S. Mendelson, et al.. (2005). A phase I clinical and pharmacokinetic (PK) study of oral CI-1033 + docetaxel (DOC) in the treatment of patients with advanced solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3111–3111. 2 indexed citations

Undevia, Samir D., Hedy L. Kindler, Linda Janisch, et al.. (2004). A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine. Annals of Oncology. 15(11). 1705–1711. 60 indexed citations

Nemunaitis, John, Casey Cunningham, Gerald M. Edelman, et al.. (2001). Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Therapy. 8(10). 746–759. 228 indexed citations

Begg, EJ, RA Robson, Sharon J. Gardiner, et al.. (2001). Quinapril and its metabolite quinaprilat in human milk. British Journal of Clinical Pharmacology. 51(5). 478–481. 16 indexed citations

Olson, S.C., et al.. (1998). In vitro metabolism of ceftiofur in bovine tissues. Journal of Veterinary Pharmacology and Therapeutics. 21(2). 112–120. 15 indexed citations

Stern, R. H., et al.. (1997). Renal Dysfunction Does Not Alter the Pharmacokinetics or LDL‐Cholesterol Reduction of Atorvastatin. The Journal of Clinical Pharmacology. 37(9). 816–819. 54 indexed citations

10.

Nasrallah, H.A. & S.C. Olson. (1996). Hypoplasia of the hippocampal formation and the entorhinal cortex detected in early-but not late-onset schizophrenia. Schizophrenia Research. 18(2-3). 186–186. 1 indexed citations

11.

Nasrallah, H.A., et al.. (1994). Increased hippocampal volume in bipolar disorder. Biological Psychiatry. 35(9). 626–626. 10 indexed citations

12.

Nasrallah, Henry A., et al.. (1993). Increased caudate volume in schizophrenia: A controlled MRI study. Schizophrenia Research. 9(2-3). 204–204. 5 indexed citations

13.

Bornstein, Robert A., Steven B. Schwarzkopf, S.C. Olson, & Henry A. Nasrallah. (1992). Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biological Psychiatry. 31(9). 954–961. 29 indexed citations

14.

Swartz, Richard D., et al.. (1990). Pharmacokinetics of Quinapril and its Active Metabolite Quinaprilat During Continuous Ambulatory Peritoneal Dialysis. The Journal of Clinical Pharmacology. 30(12). 1136–1141. 9 indexed citations

15.

Nasrallah, Henry A., Steven B. Schwarzkopf, S.C. Olson, & Jeffrey A. Coffman. (1990). Gender Differences in Schizophrenia on MRI Brain Scans. Schizophrenia Bulletin. 16(2). 205–210. 87 indexed citations

16.

Caillé, Gilles, et al.. (1990). Multiple‐dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat). Biopharmaceutics & Drug Disposition. 11(3). 191–196. 8 indexed citations

17.

Nasrallah, H.A., Jeffrey A. Coffman, Steven B. Schwarzkopf, & S.C. Olson. (1990). Reduced cerebral volume in schizophrenia. Schizophrenia Research. 3(1). 17–17. 7 indexed citations

18.

Nasrallah, Henry A., Jeffrey A. Coffman, & S.C. Olson. (1989). Structural brain-imaging findings in affective disorders: an overview. Journal of Neuropsychiatry. 1(1). 21–26. 49 indexed citations

19.

Olson, S.C., et al.. (1985). Alcohol in America : taking action to prevent abuse. 12 indexed citations

20.

Iwata, N., S.T. Kitai, & S.C. Olson. (1972). Afferent component of the facial nerve: its relation to the spinal trigeminal and facial nucleus. Brain Research. 43(2). 662–667. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact